申请人:Elf Sanofi
公开号:US05464847A1
公开(公告)日:1995-11-07
The invention relates to the derivatives of formula I: ##STR1## in which R.sub.1 represents a phenyl or naphthyl radical (optionally substituted), R.sub.2 represents a hydrogen or halogen atom or an alkyl, hydroxymethyl or formyl radical, R.sub.3 represents an alkyl, cycloalkyl, alkenyl, cycloalkylalkyl or phenyl radical, R.sub.4 represents a hydrogen atom or an alkyl, cycloalkyl or cycloalkylalkyl radical, R.sub.5 represents an alkyl, cycloalkyl, cycloalkylalkyl or alkenyl radical or a radical of formula B: ##STR2## (p=0, 1, 2 or 3), R.sub.6 represents a phenyl, pyridyl, imidazolyl, pyrrolyl, thienyl or furyl radical, optionally substituted, or a cycloalkyl radical, m and n, which may be identical or different, each represent 0 or 1, their possible stereoisomers and their addition salts.
本发明涉及式I的衍生物:##STR1## 其中R.sub.1代表苯基或萘基基团(可选择性取代),R.sub.2代表氢或卤素原子或烷基,羟甲基或甲酰基基团,R.sub.3代表烷基,环烷基,烯基,环烷基烷基或苯基基团,R.sub.4代表氢原子或烷基,环烷基或环烷基烷基基团,R.sub.5代表烷基,环烷基,环烷基烷基或烯基基团或式B的基团:##STR2## (p=0,1,2或3),R.sub.6代表苯基,吡啶基,咪唑基,吡咯基,噻吩基或呋喃基,可选择性取代或环烷基,m和n,可以相同或不同,分别代表0或1,它们的可能的立体异构体及其加合盐。